Recursion Pharmaceuticals (NASDAQ:RXRX) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Recursion Pharmaceuticals (NASDAQ:RXRX – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.34) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.01), Briefing.com reports. The company had revenue of $26.08 million for the quarter, compared to analyst estimates of $12.62 million. Recursion Pharmaceuticals had a negative net […]

Leave a Reply

Your email address will not be published.

Previous post Wedbush Reiterates “Outperform” Rating for Generation Bio (NASDAQ:GBIO)
Next post Funko (NASDAQ:FNKO) Updates Q4 Earnings Guidance